WFDC2 and ovarian carcinoma: HE4 may involve in the pathways such as MAPK signaling, ECM receptor, steroid biosynthesis pathway, etc. Elucidation of the molecular mechanism of HE4 may lead to the design of therapeutic strategies targeting HE4 for the treatment of ovarian cancer.